Search

Your search keyword '"Carrupt PA"' showing total 219 results

Search Constraints

Start Over You searched for: Author "Carrupt PA" Remove constraint Author: "Carrupt PA"
219 results on '"Carrupt PA"'

Search Results

101. Rapid determination of pK (a) values of 20 amino acids by CZE with UV and capacitively coupled contactless conductivity detections.

102. Quantitative structure-permeation relationship for iontophoretic transport across the skin.

103. Development of a two-step screening ESI-TOF-MS method for rapid determination of significant stress-induced metabolome modifications in plant leaf extracts: the wound response in Arabidopsis thaliana as a case study.

104. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.

105. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.

106. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization.

107. Ferulenol specifically inhibits succinate ubiquinone reductase at the level of the ubiquinone cycle.

108. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.

109. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.

110. Structure-permeation relationships for the non-invasive transdermal delivery of cationic peptides by iontophoresis.

111. Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.

112. Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.

113. Immobilized pH gradient gel cell to study the pH dependence of drug lipophilicity.

114. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening.

115. Novel RPLC stationary phases for lipophilicity measurement: solvatochromic analysis of retention mechanisms for neutral and basic compounds.

116. Determination of pKa values by capillary zone electrophoresis with a dynamic coating procedure.

117. A study of interlaboratory influence on column evaluation.

118. Numerical simulation of two-phase partition chromatography in microchannels for moderated log P measurements.

119. Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.

120. Fluoride curcumin derivatives: new mitochondrial uncoupling agents.

121. Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors.

122. Liposome/water lipophilicity: methods, information content, and pharmaceutical applications.

123. Analysis of basic compounds at high pH values by reversed-phase liquid chromatography.

124. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation.

125. D-LogP: an alignment-free 3D description of local lipophilicity for QSAR studies.

126. Partition coefficients of ionizable compounds in o-nitrophenyl octyl ether/water measured by the potentiometric method.

127. Water-oil partition profiling of ionized drug molecules using cyclic voltammetry and a 96-well microfilter plate system.

128. Immobilized artificial membrane HPLC in drug research.

130. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.

131. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies.

132. Quantitative structure-permeation relationships for solute transport across silicone membranes.

133. The Hydrogen-Bond: computational approaches and applications to drug design.

134. Lipophilicity and solvation of anionic drugs.

135. Theoretical and experimental exploration of the lipophilicity of zwitterionic drugs in the 1,2-dichloroethane/water system.

136. A simple model to predict blood-brain barrier permeation from 3D molecular fields.

137. Molecular factors influencing retention on immobilized artifical membranes (IAM) compared to partitioning in liposomes and n-octanol.

138. Recognition forces involved in mitochondrial binding to a low-affinity trimetazidine binding site related to anti-ischemic activity.

139. Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling.

140. Immobilized artificial membrane liquid chromatography: proposed guidelines for technical optimization of retention measurements.

141. The relative partitioning of neutral and ionised compounds in sodium dodecyl sulfate micelles measured by micellar electrokinetic capillary chromatography.

142. Generalization of ionic partition diagrams to lipophilic compounds and to biphasic systems with variable phase volume ratios.

143. The esterase-like activity of serum albumin may be due to cholinesterase contamination.

144. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase.

145. Interaction of psychotropic drugs with monoamine oxidase in rat brain.

146. Lipophilicity behaviour of the Zwitterionic antihistamine cetirizine in phosphatidylcholine liposomes/water systems.

147. The apparent lipophilicity of quaternary ammonium ions is influenced by galvani potential difference, not ion-pairing: a cyclic voltammetry study.

148. Development of molecular hydrogen-bonding potentials (MHBPs) and their application to structure-permeation relations.

149. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs.

150. Very slow chiral inversion of clopidogrel in rats: a pharmacokinetic and mechanistic investigation.

Catalog

Books, media, physical & digital resources